Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine

We report a case of a 52-year-old female with Large Vessel Vasculitis (LVV) after vaccination with Oxford-AstraZeneca COVID-19 vaccine. She was presented with fever, started two weeks after the second dose of vaccine. Laboratory values, revealed elevated inflammatory markers and chronic disease anae...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsouli, Olga K., Lainis, Vasileios G., Kapellos, Gerasimos G., Vlachoyiannopoulos, Panayiotis G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201099/
https://www.ncbi.nlm.nih.gov/pubmed/37223596
http://dx.doi.org/10.31138/mjr.34.1.97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201099/
https://www.ncbi.nlm.nih.gov/pubmed/37223596
http://dx.doi.org/10.31138/mjr.34.1.97

Ejemplares similares